Kronos Bio Inc Ordinary Shares KRON
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 60.97M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 8
- Website
- https://www.kronosbio.com
Valuation
|
Metric
|
KRON
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.67 |
Price/Sales | 5.78 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
KRON
|
|---|---|
Quick Ratio | 12.66 |
Current Ratio | 12.93 |
Interest Coverage | — |
Quick Ratio
KRON
Profitability
|
Metric
|
KRON
|
|---|---|
Return on Assets (Normalized) | −26.67% |
Return on Equity (Normalized) | −36.13% |
Return on Invested Capital (Normalized) | −33.51% |
Return on Assets
KRON
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|vj@r##% | LOCK|mPW$ | $139B | |||
| Moderna Inc
MRNA
| LOCK|yRbzYt$ | LOCK|B$^ | $103B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|<$$hq@ | LOCK|?vZD^ | $96B | |||
| argenx SE ADR
ARGX
| LOCK|#wVb>^ | LOCK|%j< | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&WZnRF | LOCK|gyZ | $45B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|T!^&<@F | LOCK|Ckg?m | $30B | |||
| Incyte Corp
INCY
| LOCK|!!@PqX | LOCK|h$x | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|?>@VWP | LOCK|Zp# | $22B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|hLb<!& | LOCK|ypcS% | $22B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|@j^XYJs | LOCK|SXY | $15B |
United States